It looks like a travel shampoo bottle, smells like bubblegum, and fits in a school bag pocket. On top of that, it costs less than a coffee. And according to a growing and convergent body of scientific research, it is very likely giving young people cancer. The vaping carcinogens inhaled with every puff are no longer a theoretical concern or a precautionary footnote. They are the documented conclusion of some of the most rigorous independent research conducted on e-cigarettes to date, and that conclusion demands a response that matches its urgency.
We have been here before. The parallels are not subtle.
The Same Story, Running Again
It took nearly a century, from the mid-1800s to the landmark US Surgeon General’s report in 1964, for smoking to be officially recognised as a cause of lung cancer. During those decades, early warning signs were dismissed, industry interests were advanced over public health, and generations of people paid the price with their lives. Researchers at UNSW Sydney, who led the most comprehensive review of e-cigarette carcinogenicity yet published, have drawn that parallel directly. Their message is unambiguous: “E-cigarettes were introduced about 20 years ago. We should not wait another 80 years to decide what to do.”
That review, published in the journal Carcinogenesis in March 2026 and led by Adjunct Professor Bernard Stewart AM, brought together experts in pharmacology, epidemiology, thoracic surgery and public health from UNSW, the University of Queensland, Flinders University, the University of Sydney and multiple major hospitals. Their conclusion, drawn from clinical monitoring, animal studies and laboratory research, was unequivocal: nicotine-based e-cigarettes are likely to cause lung cancer and oral cancer in people who use them.
“To our knowledge, this review is the most definitive determination that those who vape are at increased risk of cancer compared to those who don’t,” said Professor Stewart.
What Is Actually Being Inhaled
The marketing of e-cigarettes has always emphasised what they are not: not tobacco, not combustion and, by implication, not particularly dangerous. The science, however, tells a very different story about the vaping carcinogens concealed inside every device.
A 2025 study from the University of California, Davis tested seven types of disposable e-cigarettes from three of the most popular brands on the market. Researchers created between 500 and 1,500 puffs for each device and measured the metal concentrations in the resulting vapour. What they found stopped the lead researcher mid-analysis. “When I first saw the lead concentrations, they were so high I thought our instrument was broken,” said PhD candidate Mark Salazar.
They were not broken. One disposable e-cigarette released more lead during a single day’s use than nearly 20 packs of traditional cigarettes. Levels of chromium, nickel and antimony increased as puffing continued. Leaded bronze alloy components were leaching nickel and lead directly into the e-liquid. Heating coils were releasing additional nickel. Antimony, a known carcinogen, was present in unused e-liquids at high concentrations before a single puff had been taken.
Three of the seven devices had nickel levels in their vapour that exceeded cancer risk limits. Two had antimony levels above the same threshold. Four produced vapour with nickel and lead emissions surpassing health-risk limits for neurological damage and respiratory disease, not just cancer.
These are not obscure chemicals. Lead exposure in young people causes irreversible neurological damage. Nickel and antimony are known carcinogens. Chromium compounds at elevated concentrations are associated with lung cancer. They are not the ingredients of a harm-reduction device. They are the contents of a product being sold to teenagers outside school gates across Australia.
The Cancer Pathway
The UNSW-led review in Carcinogenesis examined how vaping carcinogens drive cancer risk at a biological level, drawing on biomarker studies, animal experiments and mechanistic laboratory research. The findings across all three categories pointed in the same direction.
In human biomarker studies, researchers identified DNA damage correlated with vape-derived metabolites from carcinogens including nicotine-derived nitrosamines, volatile organic compounds, flavour-derived agents and metals. Vaping-attributable oxidative stress, epigenetic change and inflammation were found in oral and respiratory tissue. In animal experiments, inhalation exposure to e-cigarette aerosol caused lung adenocarcinomas in mice. Mechanistic data, analysed using the key characteristics of carcinogens, pointed to a complex chemical mixture causing cancer via both genotoxic and other biological processes.
The evidence, as co-author Associate Professor Freddy Sitas put it, “was remarkably consistent across fields.” E-cigarette carcinogenicity is not a single study’s finding. It is the convergent conclusion of multiple disciplines of investigation, reviewed across an eight-year period from 2017 to 2025.
The Dual-Use Trap
Vaping was introduced and marketed, in Australia and internationally, as a tool for quitting smoking. The Australian government’s 2023 regulations reflect this framing: disposable vapes are banned, while therapeutic vapes may be sold only in pharmacies and only to support smoking cessation. It is a reasonable regulatory position. The problem is that it does not match what is actually happening.
Most people who use e-cigarettes to quit smoking do not quit. Instead, according to A/Prof. Sitas, they end up in what he describes as “dual-use limbo”, unable to stop smoking and unable to stop vaping, now carrying both habits simultaneously. Epidemiological data from the United States shows that people who both vape and smoke are at a four-fold increased risk of developing lung cancer compared to those who only smoke. The device sold as a solution is, for many, compounding the problem.
The reach of vaping carcinogens into the youngest cohorts makes this more alarming still. Most consumers of disposable e-cigarettes, the very devices found to emit the highest concentrations of toxic metals, are teenagers and young adults. These are the people whose neurological systems are most susceptible to lead exposure, whose lung tissue is still developing, and who are being reached by a product that smells like bubblegum, comes in hundreds of varieties and remains widely accessible despite its illegal status in Australia.
The Market Outrunning the Science
The UC Davis researchers made a point that should be impossible to overlook. The market for disposable e-cigarettes is outpacing the science. Few studies of the relatively new devices are available. Consumers and regulators are largely uninformed. The nearly 100 disposable e-cigarette brands currently on the market have not been systematically tested. The seven devices studied by UC Davis represent a fraction of what is being sold, carried and inhaled, including by children who have never smoked a cigarette in their lives.
E-cigarette carcinogenicity research, as the Carcinogenesis review makes clear, has moved over eight years from calling for more evidence to issuing firm warnings. The science has done its job. The question now is whether the response, regulatory, social and institutional, will move at the pace the evidence demands, or whether it will take another generation and another body count before the message lands.
Smoking killed millions while the world waited for certainty. The bubblegum-flavoured version of that story is already in progress. The vaping carcinogens are identified. The cancer pathway is documented. The evidence does not require more time. It requires action.
(Source: WRD News)